Kanakkanthara A, Hou X, Ekstrom TL, Zanfagnin V, et al. Repurposing ceritinib induces DNA damage and enhances PARP inhibitor responses in high-grade serous ovarian carcinoma. Cancer Res 2021 Nov 22. pii: 0008-5472.CAN-21-0732.
PMID: 34810199